Veracyte, Inc. VCYT
51.47 USD +1.18 (+2.34%)
Nov 4, 2026, 2:28 PM EST
49.29 Day range 52.46
29.46 52-week range 60.91
- YTD
- +22.24%
- 1 year
- +42.48%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.73 +16.1% upside
Now 51.47
- Target (low)
- 45.00
- Target (mean)
- 59.73
- Target (high)
- 70.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
- Strong buy2
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 13
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.40973 | 0.35 – 0.45 | 0.51 | -19.7% | 147.16M | +11.6% | 11 |
| Next quarter | 0.44563 | 0.36 – 0.50 | 0.53 | -15.9% | 157.29M | +11.8% | 11 |
| Current year | 1.91 | 1.78 – 1.99 | 1.78 | +7.2% | 593.80M | +14.8% | 11 |
| Next year | 1.94 | 1.67 – 2.11 | 1.91 | +1.8% | 660.07M | +11.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 2026 | Freedom Capital Markets | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 31, 2026 | Needham | Maintained | Buy | Buy |
| Jul 30, 2026 | Needham | Maintained | Buy | Buy |
| Jul 15, 2026 | Piper Sandler | Initiated | Overweight | Overweight |
| Jul 14, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 9, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 1, 2026 | Needham | Maintained | Buy | Buy |
| May 28, 2026 | Needham | Reiterated | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| May 6, 2026 | UBS | Maintained | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Apr 13, 2026 | Jefferies | Initiated | — | Buy |
| Apr 1, 2026 | Needham | Maintained | Buy | Buy |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 6, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Feb 26, 2026 | Needham | Maintained | Buy | Buy |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 2, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 11, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 5, 2025 | UBS | Maintained | Buy | Buy |
| Nov 5, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Nov 5, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 5, 2025 | Needham | Maintained | Buy | Buy |
| Oct 20, 2025 | Canaccord Genuity | Initiated | — | Hold |